Financial Management Professionals’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Financial Management Professionals’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-74,145	Closed	-$3.19M	–	651
2020 Q2	$3.19M	Sell	74,145 -1,458	-2%	-$60.3K	1.1%	18
2020 Q1	$2.73M	Buy	+75,603	New	+$3.22M	1.16%	16

Other funds holding XPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Financial Management Professionals's XPH Position: Q3 2020 in Review

Financial Management Professionals sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2020, closing a stake of 74,145 shares — an estimated $3.19M sold.

Financial Management Professionals first reported a position in XPH in Q1 2020 and held it in 2 quarters. The position peaked at $3.19M in Q2 2020. 72 funds tracked by Wall St. Rank hold XPH as of Q3 2020.

Financial Management Professionals reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2020 after selling out during the quarter.
Financial Management Professionals sold 74,145 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2020, an estimated $3.19M.
Financial Management Professionals first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2020 and held it in 2 quarters.
Financial Management Professionals's State Street SPDR S&P Pharmaceuticals ETF position peaked at $3.19M in Q2 2020.
72 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2020.

Based on Financial Management Professionals's 13F filing for Q3 2020, filed 26 Oct 2020.